Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulation of KCNH2 isoform expression by oligonucleotides as a therapeutic approach for long QT syndrome

Modulation of KCNH2 isoform expression by oligonucleotides as a therapeutic approach for long QT syndrome

US Patent 9957508 · Granted May 1, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Flexible printed circuit board and display apparatus2025
Iterative hierarchical processing and validation of hierarchical data in a tempo2025
Touch sensor and display apparatus2025
Modulation of KCNH2 isoform expression by oligonucleotides as a therapeutic appr2016
Modulation of KCNH2 isoform expression by oligonucleotides as a therapeutic appr2016
Modulation of KCNH2 isoform expression by oligonucleotides as a therapeutic appr2016